Compare BLTE & MGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLTE | MGY |
|---|---|---|
| Founded | 2018 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.0B |
| IPO Year | 2022 | 2017 |
| Metric | BLTE | MGY |
|---|---|---|
| Price | $169.05 | $25.53 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 14 |
| Target Price | ★ $161.57 | $25.92 |
| AVG Volume (30 Days) | 237.7K | ★ 2.5M |
| Earning Date | 03-16-2026 | 02-05-2026 |
| Dividend Yield | N/A | ★ 2.38% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.80 |
| Revenue | N/A | ★ $1,320,826,000.00 |
| Revenue This Year | N/A | $0.77 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $14.02 |
| Revenue Growth | N/A | ★ 0.68 |
| 52 Week Low | $49.00 | $19.09 |
| 52 Week High | $174.78 | $26.24 |
| Indicator | BLTE | MGY |
|---|---|---|
| Relative Strength Index (RSI) | 64.28 | 76.85 |
| Support Level | $156.52 | $23.79 |
| Resistance Level | $171.63 | $24.53 |
| Average True Range (ATR) | 8.88 | 0.57 |
| MACD | 0.26 | 0.33 |
| Stochastic Oscillator | 79.00 | 78.59 |
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.
Magnolia Oil & Gas Corp is an independent oil and natural gas company engaged in the acquisition, development, exploration, and production of oil, natural gas, and natural gas liquid (NGL) reserves. The company's oil and natural gas properties are located in Karnes County and the Giddings area in South Texas, where the Company targets the Eagle Ford Shale and Austin Chalk formations. Its objective is to generate stock market value over the long term through consistent organic production growth, high full-cycle operating margins, and an efficient capital program with short economic paybacks. The company's operating segment is acquisition, development, exploration, and production of oil and natural gas properties located in the United States.